NASA is mulling an unprecedented early departure of its crew from the International Space Station (ISS) due to a medical emergency involving one of the astronauts. The decision comes after cancelling a planned spacewalk that was set to take place on Thursday, citing a need for caution.
According to NASA officials, the astronaut in question is currently stable and receiving treatment for their condition. However, the agency has deemed it safer to bring the crew back sooner rather than risk any further complications or potential health issues.
The ISS typically hosts crews who stay on board for six- to eight-month stints, with basic medical facilities and emergency medications available for minor incidents. But in this case, NASA is taking a more cautious approach, considering an earlier end to its Crew-11 mission, which had initially been scheduled to conclude around May this year.
The four-person crew includes US astronauts Zena Cardman and Mike Fincke, Japanese astronaut Kimiya Yui, and Russian cosmonaut Oleg Platonov. The spacewalk that was cancelled was set to be a crucial part of their schedule, involving a 6.5-hour mission outside the station to install hardware.
NASA's reluctance to disclose details about medical issues affecting its astronauts is well-documented. Typically, these situations remain private and are not publicly acknowledged by the agency. However, in this instance, officials have chosen to err on the side of caution, opting for an earlier return instead of pushing through with a potentially risky spacewalk.
This decision marks a rare deviation from NASA's usual cautious approach when it comes to spacewalks. As past examples demonstrate – including 2021's cancellation due to a pinched nerve and 2024's swift call-off at the last minute over "spacesuit discomfort" – even minor medical issues can prove arduous for astronauts on long-duration missions like the ISS.
According to NASA officials, the astronaut in question is currently stable and receiving treatment for their condition. However, the agency has deemed it safer to bring the crew back sooner rather than risk any further complications or potential health issues.
The ISS typically hosts crews who stay on board for six- to eight-month stints, with basic medical facilities and emergency medications available for minor incidents. But in this case, NASA is taking a more cautious approach, considering an earlier end to its Crew-11 mission, which had initially been scheduled to conclude around May this year.
The four-person crew includes US astronauts Zena Cardman and Mike Fincke, Japanese astronaut Kimiya Yui, and Russian cosmonaut Oleg Platonov. The spacewalk that was cancelled was set to be a crucial part of their schedule, involving a 6.5-hour mission outside the station to install hardware.
NASA's reluctance to disclose details about medical issues affecting its astronauts is well-documented. Typically, these situations remain private and are not publicly acknowledged by the agency. However, in this instance, officials have chosen to err on the side of caution, opting for an earlier return instead of pushing through with a potentially risky spacewalk.
This decision marks a rare deviation from NASA's usual cautious approach when it comes to spacewalks. As past examples demonstrate – including 2021's cancellation due to a pinched nerve and 2024's swift call-off at the last minute over "spacesuit discomfort" – even minor medical issues can prove arduous for astronauts on long-duration missions like the ISS.